This facility is a former Roche manufacturing plant acquired by the Martin Dow Group in 2010. The facility is cGMP compliant, and develops, produces, and manufactures top-quality branded products and generics. We have dedicated psychotropic and DPI manufacturing facility.
This facility was founded in the year 2000 by the Martin Dow Group as a manufacturing facility. The plant follows cGMP guidelines and produces high-quality generics and branded products. We have dedicated psychotropic and cephalosporin manufacturing areas.